ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2021 American Transplant Congress

    Engineered Human Glomerular Endothelial Cells to Identify Non-hla Antibodies and Decipher Their Pathogenicity After Kidney Transplantation

    B. Lamarthée1, C. Burger1, C. Leclaire1, L. Morin1, F. Terzi1, C. Tinel1, D. Anglicheau2

    1Inserm U1151, Necker-Enfants Malades Institute, PARIS, France, 2Necker Hospital, AP-HP, Department of Nephrology and Kidney Transplantation, PARIS, France

    *Purpose: In kidney transplantation recipients (KTRs), donor-specific antibodies directed against Human Leucocyte Antigens (HLA-DSA) are thought to drive antibody-mediated rejection (AMR) and poor transplant outcome.…
  • 2021 American Transplant Congress

    The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis

    J. Kumar1, J. Pyda2, I. Reccia3, F. VIrdis4, P. Bachul1, R. Barth1, Y. Becker1, J. Fung1, P. Witkowski1

    1University of Chicago, Chicago, IL, 2Beth Israel, Boston, MA, 3Imperial College, London, United Kingdom, 4Royal London, London, United Kingdom

    *Purpose: To determine pooled prevalence of clinical outcomes among hospitalized kidney transplant recipients with COVID-19 through meta-analysis.*Methods: A systematic database search between Dec1, 2019- Dec1,…
  • 2021 American Transplant Congress

    Anti-CD8 Immuno-PET for Non-invasive Tracking of Early Graft Rejection in a Non-human Primate Kidney Transplant Model

    K. Bruestle1, R. Tavare2, F. Fredriksson1, E. Duggan1, F. Huang1, B. Bhola1, J. Giurleo2, R. Foster2, P. Krueger2, M. Dobosz2, D. Ekanayake-Alper1, H. Sakai1, B. Piegari1, J. Castrillion1, S. M. Coley1, O. Harari2, A. Mintz1, D. Ma2, A. Griesemer1

    1Columbia University Medical Center, New York City, NY, 2Regeneron Pharmaceuticals, Inc, New York City, NY

    *Purpose: Infiltration of CD8 T cells into solid organ grafts is an early sign of rejection. REGN5054 is a fully human monoclonal antibody that binds…
  • 2021 American Transplant Congress

    Belatacept Pharmacokinetic Analysis Comparing Belatacept Early Steroid Withdrawal Trial (BEST) with Benefit and Benefit-ext Trials

    A. Bickenbach1, M. McGowan1, B. Miyagawa2, T. Mizuno2, A. Shields3, A. Christianson1, P. West-Thielke4, J. Leone5, E. Woodle1, D. Kaufman6, A. Wiseman7, A. Matas8, A. Vinks2

    1U Cincinnati, Cincinnati, OH, 2Cincinnati Childrens Med Center, Cincinnati, OH, 3Christ Hospital, Cincinnati, OH, 4UIC, Chicago, IL, 5Tampa Gen, Tampa, FL, 6U Wisconsin, Madison, WI, 7Centura Transplant, Denver, CO, 8U Minnesota, Minneapolis, MN

    *Purpose: Belatacept(BELA) pharmacokinetic(PK) studies informed dosing in phase 3 studies where fixed mg/kg dosing compared a less intense(LI) and more intense(MI) regimen. LI was preferred…
  • 2021 American Transplant Congress

    Angiotensin II Type-1 Receptor Antibodies are Associated with Inferior Renal Allograft Survival

    P. Martin, E. Santos, N. Gunby, M. Willicombe

    Renal Department, Imperial College Healthcare NHS Trust, London, United Kingdom

    *Purpose: AT1R-antibodies have been implicated in antibody-mediated vascular rejection in the absence of detectable HLA donor specific antibody (DSA), in addition to cardiovascular diseases. Transplant…
  • 2021 American Transplant Congress

    MDR-101-MLK-MERCURY Kidney Transplant Tolerance Study Update

    D. Kaufman1, S. Akkina2, M. Stegall3, J. Piper4, A. O. Gaber5, E. Marin6, S. Busque7, D. Alonso8, M. De Vera9, A. Shah10, A. Patel11, K. Chavin12, M. Laftavi13, S. Collette14, E. Stites15, M. Mai16, M. Cooper17, D. Brennan18

    1Surgery, UW, Madison, WI, 2Surgery, Loyola, Chicago, IL, 3Surgery, Mayo, Rochester, MN, 4Surgery, Inova, Fairfax, VA, 5Surgery, Houston Methodist, Houston, TX, 6Nephrology, Yale, New Haven, CT, 7Surgery, Stanford, San Francisco, CA, 8Surgery, Intermountain, Murray, UT, 9Surgery, Loma Linda, Loma Linda, CA, 10Surgery, TJU, Philadelphia, PA, 11Nephrology, St. Barnabas, Livingston, NJ, 12Surgery, UHH, Cincinnati, OH, 13Surgery, Upstate, Syracuse, NY, 14Surgery, CIUSSS, Montreal, ON, Canada, 15Nephrology, UC Denver, Denver, CO, 16Nephrology, Mayo - FL, Jacksonville, FL, 17Surgery, Georgetown, Washington, DC, 18Medeor, San Francisco, CA

    *Purpose: We report interim results of the Phase 3 MERCURY tolerance study, which produces mixed chimerism and ultimately generates operational tolerance allowing for the elimination…
  • 2021 American Transplant Congress

    Initial Kidney Transplant Evaluations with Telehealth: Is it a Pandemic Only Practice?

    A. Govil1, E. Tims2, C. Siemer2, J. Harris2, C. King2, S. Shah1, C. Thakar1

    1Univ of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH

    *Purpose: COVID -19 pandemic presented an unprecedented challenge to health care systems. It disrupted the transplant processes including evaluations, especially in rural or other geographically…
  • 2021 American Transplant Congress

    Transplant Glomerulopathy in the Absence of Donor-specific HLA Antibodies: Risk Factors, Histopathological Features and Graft Outcome

    A. Senev, E. Van Loon, M. Emonds, M. Naesens

    Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium

    *Purpose: Transplant glomerulopathy (TG) is established as a hallmark of chronic antibody-mediated rejection in kidney transplant patients with donor-specific HLA antibodies (HLA-DSA). The clinical importance…
  • 2021 American Transplant Congress

    Outcomes of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants

    G. Gupta, I. Yakubu, P. Kimball, L. Kang, K. Mitchell, M. Shinbashi, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, M. Levy, A. Cotterell, A. Sharma, R. Sterling

    Virginia Commonwealth University Health System, Richmond, VA

    *Purpose: Trials describing 4-12 week courses of direct-acting anti-viral drugs (DAAs) to treat hepatitis C virus (HCV) transmission from infected donors to uninfected kidney transplant…
  • 2021 American Transplant Congress

    Compatible Paired Donation in Paired Kidney Exchange: A Look at the Road Not Taken

    G. Vranic, A. Gilbert, B. Thomas, S. Ghasemian, M. Cooper, J. Verbesey

    MedStar Georgetown Transplant Institute, Washington, DC

    *Purpose: Paired kidney exchange (PKE) offers incompatible donor-recipient pairs increased access to transplant. Compatible pairs are increasingly joining the PKE in an effort to find…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences